Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

(2017) Kohei Shitara et al.   Oncotarget

Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis

(2017) Franziska Paech et al.   Frontiers in Pharmacology

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

(2015) J S L Kloth et al.   BRITISH JOURNAL OF CANCER

Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection

(2015) Lara Testai et al.   CARDIOVASCULAR RESEARCH

IKsGain- and Loss-of-Function in Early-Onset Lone Atrial Fibrillation

(2015) ANNETTE BUUR STEFFENSEN et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors

(2014) L. R. Molife et al.   CLINICAL CANCER RESEARCH

Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer

(2014) A. Jo Chien et al.   JOURNAL OF CLINICAL ONCOLOGY

Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs

(2013) Norbert Jost et al.   JOURNAL OF PHYSIOLOGY-LONDON

Diazoxide Reduces Status Epilepticus Neuron Damage in Diabetes

(2009) Chin-Wei Huang et al.   NEUROTOXICITY RESEARCH

Time-Dependent Block of Ultrarapid-Delayed Rectifier K+ Currents by Aconitine, a Potent Cardiotoxin, in Heart-Derived H9c2 Myoblasts and in Neonatal Rat Ventricular Myocytes

(2008) Ya-Jean Wang et al.   TOXICOLOGICAL SCIENCES